M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal ArticleDOI
Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.
Shigeru Kusumoto,Yasuhito Tanaka,Ritsuro Suzuki,Takashi Watanabe,Masanobu Nakata,Hirotaka Takasaki,Noriyasu Fukushima,Takuya Fukushima,Yukiyoshi Moriuchi,Kuniaki Itoh,Kisato Nosaka,Ilseung Choi,Masashi Sawa,Rumiko Okamoto,Hideki Tsujimura,Toshiki Uchida,Sachiko Suzuki,Masataka Okamoto,Tsutomu Takahashi,Isamu Sugiura,Yasushi Onishi,Mika Kohri,Shinichiro Yoshida,Rika Sakai,Minoru Kojima,Hiroyuki Takahashi,Akihiro Tomita,Dai Maruyama,Yoshiko Atsuta,Eiji Tanaka,Takayo Suzuki,Tomohiro Kinoshita,Michinori Ogura,Masashi Mizokami,Ryuzo Ueda +34 more
TL;DR: A multicenter prospective observational study to estimate the incidence ofHBV reactivation by serial monthly monitoring of HBV DNA in HBV-resolved patients with B-NHL during and just after R-chemo, and to establish preemptive antiviral therapy guided by this monitoring.
Journal ArticleDOI
Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan.
Masashi Mizokami,Yasuhito Tanaka +1 more
TL;DR: Long-term serial serum samples containing hepatitis C virus (HCV) from the US and Japan were molecularly clocked to determine the time-origin of the HCV epidemic and predicted that the burden of HCC in the US will accelerate in the next two to three decades.
Journal ArticleDOI
Natural history of outpatient-onset ischemic colitis compared with other lower gastrointestinal bleeding: a long-term cohort study
Naoyoshi Nagata,Ryota Niikura,Tomonori Aoki,Takuro Shimbo,Yoshihiro Kishida,Katsunori Sekine,Shohei Tanaka,Hidetaka Okubo,Kazuhiro Watanabe,Toshiyuki Sakurai,Chizu Yokoi,Junichi Akiyama,Mikio Yanase,Masashi Mizokami,Naomi Uemura +14 more
TL;DR: Outpatient-onset ischemic colitis patients usually had left-sided colitis, recovered with conservative short-term treatment and had lower transfusion requirements and further bleeding compared with other LGIB patients.
Journal ArticleDOI
Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort
Suguru Nishijima,Naoyoshi Nagata,Yuya Kiguchi,Yasushi Kojima,Tohru Miyoshi-Akiyama,Moto Kimura,Mitsuru Ohsugi,Kohjiro Ueki,Shinichi Oka,Masashi Mizokami,Takao Itoi,Takashi Kawai,Naomi Uemura,Masahira Hattori +13 more
TL;DR: In this article , the authors analyzed the gut dsDNA virome in the Japanese 4D cohort of 4198 deeply phenotyped individuals and identified 97 various intrinsic/extrinsic factors that significantly affect the virome structure, including age, sex, lifestyle, and diet.
Journal ArticleDOI
Genome-Wide Association Study Reveals Host Genetic Factors for Liver Diseases.
TL;DR: The technological aspects of the GWAS strategy are described with examples from actual GWAS reports related to hepatitis research, including drug response for patients with chronic hepatitis C, susceptibility to primary biliary cirrhosis, and hepatitis-B-related hepatocellular carcinoma.